{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:40:26Z","timestamp":1788273626537,"version":"build-2803163510"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["\\u2212 429,302\/2018\\u20135"],"award-info":[{"award-number":["\\u2212 429,302\/2018\\u20135"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005667","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa e Inova\u00e7\u00e3o do Estado de Santa Catarina","doi-asserted-by":"publisher","award":["Universal 12\/2020-2021TR000640"],"award-info":[{"award-number":["Universal 12\/2020-2021TR000640"]}],"id":[{"id":"10.13039\/501100005667","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.pnpbp.2024.111129","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T16:52:10Z","timestamp":1724431930000},"page":"111129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Classic psychedelics and the treatment for alcoholism"],"prefix":"10.1016","volume":"135","author":[{"given":"Guilherme","family":"Lodetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Mariano","family":"de Bitencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Pacheco","family":"Rico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2024.111129_bb0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1037\/adb0000935","article-title":"Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: an interpretive phenomenological analysis","volume":"38","author":"Agin-Liebes","year":"2024","journal-title":"Psychol. Addict. Behav."},{"key":"10.1016\/j.pnpbp.2024.111129_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113546","article-title":"Ayahuasca, a psychedelic beverage, modulates neuroplasticity induced by ethanol in mice","volume":"416","author":"Almeida","year":"2022","journal-title":"Behav. Brain Res."},{"issue":"9","key":"10.1016\/j.pnpbp.2024.111129_bb0015","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1111\/acer.12503","article-title":"Lentiviral vector-mediated dopamine d3 receptor modulation in the rat brain impairs alcohol intake and ethanol-induced conditioned place preference","volume":"38","author":"Bahi","year":"2014","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.pnpbp.2024.111129_bb0020","first-page":"136","article-title":"Assessment of alcohol and tobacco use disorders among religious users of ayahuasca","volume":"9","author":"Barbosa","year":"2018","journal-title":"Front. Psychol."},{"issue":"17","key":"10.1016\/j.pnpbp.2024.111129_bb0025","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1007\/s00213-017-4653-2","article-title":"Effects of the serotonin 2C receptor agonist WAY163909 on the abuse-related effects and mesolimbic dopamine neurochemistry induced by abused stimulants in rhesus monkeys","volume":"234","author":"Berro","year":"2017","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111129_bb0030","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J. psychopharmacol. Oxford Engl."},{"issue":"9","key":"10.1016\/j.pnpbp.2024.111129_bb0035","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s40263-020-00748-y","article-title":"Psychedelic treatments for psychiatric disorders: a systematic review and thematic synthesis of patient experiences in qualitative studies","volume":"34","author":"Breeksema","year":"2020","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111129_bb0040","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neubiorev.2008.09.002","article-title":"Default-mode brain dysfunction in mental disorders: a systematic review","volume":"33","author":"Broyd","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111129_bb0045","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1021\/acschemneuro.8b00692","article-title":"Chronic, intermittent microdoses of the psychedelic N,N-dimethyltryptamine (DMT) produce positive effects on mood and anxiety in rodents","volume":"10","author":"Cameron","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111129_bb0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/0269881116677104","article-title":"The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens","volume":"31","author":"Canal","year":"2017","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111129_bb0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/YCO.0000000000000467","article-title":"How do psychedelics work?","volume":"32","author":"Carhart-Harris","year":"2019","journal-title":"Curr. Opin. Psychiatry"},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111129_bb0060","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/npp.2017.84","article-title":"The therapeutic potential of psychedelic drugs: past, present, and future","volume":"42","author":"Carhart-Harris","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"15","key":"10.1016\/j.pnpbp.2024.111129_bb0065","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pnpbp.2024.111129_bb0070","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3389\/fphar.2018.00561","article-title":"Ayahuasca and its DMT- and \u03b2-carbolines - containing ingredients block the expression of ethanol-induced conditioned place preference in mice: role of the treatment environment","volume":"9","author":"Cata-Preta","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111129_bb0075","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1590\/1806-9282.61.04.381","article-title":"A review on alcohol: from the central action mechanism to chemical dependency","volume":"61","author":"Costardi","year":"2015","journal-title":"Rev. Associacao Med. Bras. (1992)"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111129_bb0080","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1590\/1516-4446-2018-0140","article-title":"Acute effects of ayahuasca in a juvenile non-human primate model of depression","volume":"41","author":"da Silva","year":"2019","journal-title":"Rev. bras. de psiquiatria (Sao Paulo, Braz.\u202f: 1999)"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111129_bb0085","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41591-022-01744-z","article-title":"Increased global integration in the brain after psilocybin therapy for depression","volume":"28","author":"Daws","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.pnpbp.2024.111129_bb0090","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/BF00405254","article-title":"Self-administration of psychoactive substances by the monkey","volume":"16","author":"Deneau","year":"1969","journal-title":"Psychopharmacologia"},{"issue":"10","key":"10.1016\/j.pnpbp.2024.111129_bb0095","doi-asserted-by":"crossref","first-page":"ITC145","DOI":"10.7326\/AITC202210180","article-title":"Alcohol use","volume":"175","author":"Donroe","year":"2022","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111129_bb0100","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/2045125316638008","article-title":"Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years","volume":"6","author":"Dos Santos","year":"2016","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111129_bb0105","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/13634615211036388","article-title":"The socialization of hallucinations: cultural priors, social interactions, and contextual factors in the use of psychedelics","volume":"59","author":"Dupuis","year":"2022","journal-title":"Transcult. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111129_bb0110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drugalcdep.2010.03.024","article-title":"Assessment of addiction severity among ritual users of ayahuasca","volume":"111","author":"F\u00e1bregas","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pnpbp.2024.111129_bb0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fphar.2016.00035","article-title":"The therapeutic potentials of ayahuasca: possible effects against various diseases of civilization","volume":"7","author":"Frecska","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.pnpbp.2024.111129_bb0120","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1177\/0269881119845793","article-title":"Cessation and reduction in alcohol consumption and misuse after psychedelic use","volume":"33","author":"Garcia-Romeu","year":"2019","journal-title":"J. psychopharmacol. Oxford Engl."},{"key":"10.1016\/j.pnpbp.2024.111129_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114865","article-title":"Ayahuasca blocks ethanol preference in an animal model of dependence and shows no acute toxicity","volume":"285","author":"Gianfratti","year":"2022","journal-title":"J. Ethnopharmacol."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111129_bb0130","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/02791072.2020.1789247","article-title":"Pilot evaluation of a residential drug addiction treatment combining traditional amazonian medicine, ayahuasca and psychotherapy on depression and anxiety","volume":"52","author":"Giovannetti","year":"2020","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.pnpbp.2024.111129_bb0135","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.vascn.2016.07.004","article-title":"An intravenous self-administration procedure for assessing the reinforcing effects of hallucinogens in nonhuman primates","volume":"82","author":"Goodwin","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"12","key":"10.1016\/j.pnpbp.2024.111129_bb0140","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. psychopharmacol. Oxford Engl."},{"key":"10.1016\/j.pnpbp.2024.111129_bb0145","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s12231-008-9033-8","article-title":"Hallucinogenic mushrooms in Mexico: an overview","volume":"62","author":"Guzm\u00e1n","year":"2008","journal-title":"Econ. Bot."},{"key":"10.1016\/j.pnpbp.2024.111129_bb0150","series-title":"LSD: My Problem Child","author":"Hofmann","year":"2013"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111129_bb0155","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1124\/pr.114.009514","article-title":"Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder","volume":"67","author":"Howell","year":"2015","journal-title":"Pharmacol. Rev."},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111129_bb0160","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1177\/0269881114548296","article-title":"Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction","volume":"28","author":"Johnson","year":"2014","journal-title":"J. psychopharmacol. Oxford Engl."},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111129_bb0165","first-page":"858","article-title":"The treatment gap in mental health care","volume":"82","author":"Kohn","year":"2004","journal-title":"Bull. World Health Organ."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111129_bb0170","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1177\/0269881112439253","article-title":"Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials","volume":"26","author":"Krebs","year":"2012","journal-title":"J. psychopharmacol. Oxford Engl."},{"key":"10.1016\/j.pnpbp.2024.111129_bb0175","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00005053-196312000-00007","article-title":"Reactions to psilocybin administered in a supportive environment","volume":"137","author":"Leary","year":"1963","journal-title":"J. Nerv. Ment. Dis."},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111129_bb0180","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.pnpbp.2024.111129_bb0185","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrd4627","article-title":"Zebrafish as tools for drug discovery","volume":"14","author":"MacRae","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111129_bb0190","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1360-0443.2012.04054.x","article-title":"Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?","volume":"108","author":"Maisel","year":"2013","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111129_bib377","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00213-005-2183-9","article-title":"Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis","volume":"180","author":"Marona-Lewicka","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2024.111129_bb0195","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/7854_2016_472","article-title":"New World tryptamine hallucinogens and the neuroscience of ayahuasca","volume":"36","author":"McKenna","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"47","key":"10.1016\/j.pnpbp.2024.111129_bb0200","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh2399","article-title":"Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism","volume":"7","author":"Meinhardt","year":"2021","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111129_bb0205","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1360-0443.2002.00019.x","article-title":"Mesa grande: a methodological analysis of clinical trials of treatments for alcohol use disorders","volume":"97","author":"Miller","year":"2002","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111129_bb0210","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/acps.12818","article-title":"Increased thalamic resting-state connectivity as a core driver of LSD-induced hallucinations","volume":"136","author":"M\u00fcller","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.pnpbp.2024.111129_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.788155","article-title":"Therapeutic alliance and rapport modulate responses to psilocybin assisted therapy for depression","volume":"12","author":"Murphy","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111129_bb0220","series-title":"Archaeology and Psychoactive Plants. Ethnobotany: Evolution of a Discipline","first-page":"393","author":"Naranjo","year":"1995"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111129_bb0225","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/0269881113504017","article-title":"The role of the opioid system in alcohol dependence","volume":"28","author":"Nutt","year":"2014","journal-title":"J. psychopharmacol. Oxford Engl."},{"key":"10.1016\/j.pnpbp.2024.111129_bb0230","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S0140-6736(10)61462-6","article-title":"Drug harms in the UK: a multicriteria decision analysis","volume":"376","author":"Nutt","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111129_bb0235","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2020.03.020","article-title":"Psychedelic psychiatry's brave new world","volume":"181","author":"Nutt","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.pnpbp.2024.111129_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109257","article-title":"Psychedelics therapeutics: what we know, what we think, and what we need to research","volume":"223","author":"Nutt","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2024.111129_bb0245","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.physbeh.2015.01.032","article-title":"Effects of ayahuasca on the development of ethanol-induced behavioral sensitization and on a post-sensitization treatment in mice","volume":"142","author":"Oliveira-Lima","year":"2015","journal-title":"Physiol. Behav."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111129_bb0250","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/02791072.2001.10400574","article-title":"Pharma\u00f1opo-psychonautics: human intranasal, sublingual, intrarectal, pulmonary and oral pharmacology of bufotenine","volume":"33","author":"Ott","year":"2001","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.pnpbp.2024.111129_bb0255","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1038\/s41598-024-52967-8","article-title":"Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot study","volume":"14","author":"Pagni","year":"2024","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111129_bb0260","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/add.13974","article-title":"Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate","volume":"113","author":"Palpacuer","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.pnpbp.2024.111129_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.884703","article-title":"Changes in mental health, wellbeing and personality following ayahuasca consumption: results of a naturalistic longitudinal study","volume":"13","author":"Perkins","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"101","key":"10.1016\/j.pnpbp.2024.111129_bb0270","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2014.0873","article-title":"Homological scaffolds of brain functional networks","volume":"11","author":"Petri","year":"2014","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.pnpbp.2024.111129_bb0275","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.35082","article-title":"Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor","volume":"7","author":"Preller","year":"2018","journal-title":"Elife"},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111129_bb0280","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1073\/pnas.1815129116","article-title":"Effective connectivity changes in LSD-induced altered states of consciousness in humans","volume":"116","author":"Preller","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111129_bb0285","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.biopsych.2019.12.027","article-title":"Psilocybin induces time-dependent changes in global functional connectivity","volume":"88","author":"Preller","year":"2020","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111129_bb0290","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/adb.12747","article-title":"Naltrexone effects on subjective responses to alcohol in the human laboratory: a systematic review and meta-analysis","volume":"24","author":"Ray","year":"2019","journal-title":"Addict. Biol."},{"key":"10.1016\/j.pnpbp.2024.111129_bb0295","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41398-023-02690-1","article-title":"Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats","volume":"13","author":"Reinwald","year":"2023","journal-title":"Transl. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111129_bb0300","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/dta.1685","article-title":"Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: a comparative study","volume":"7","author":"Riba","year":"2015","journal-title":"Drug Test Anal."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111129_bb0305","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.psc.2012.04.002","article-title":"Serotonergic hallucinogens and emerging targets for addiction pharmacotherapies","volume":"35","author":"Ross","year":"2012","journal-title":"Psychiatr. Clin. North Am."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111129_bb0310","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/ADM.0b013e318166af74","article-title":"The case for chronic disease management for addiction","volume":"2","author":"Saitz","year":"2008","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.pnpbp.2024.111129_bb0315","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1037\/pha0000253","article-title":"Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats","volume":"27","author":"Sakloth","year":"2019","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111129_bb0320","series-title":"Plants of the Gods: Their Sacred, Healing, and Hallucinogenic Powers","author":"Schultes","year":"2001"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111129_bib378","doi-asserted-by":"crossref","first-page":"15","DOI":"10.35946\/arcr.v37.1.02","article-title":"Advances in Medications and Tailoring Treatment for Alcohol Use Disorder","volume":"37","author":"Seneviratne","year":"2015","journal-title":"Alcohol Res."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111129_bb0325","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s00213-022-06104-w","article-title":"Role of 5-HT2A receptors in the effects of ayahuasca on ethanol self-administration using a two-bottle choice paradigm in male mice","volume":"239","author":"Serra","year":"2022","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111129_bb0330","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/0269881121991792","article-title":"First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder","volume":"35","author":"Sessa","year":"2021","journal-title":"J. psychopharmacol. Oxford Engl."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111129_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087366","article-title":"Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis","volume":"9","author":"Skinner","year":"2014","journal-title":"PLoS One"},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2024.111129_bb0340","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1055\/s-0029-1220690","article-title":"Mechanistic studies of ethanol\u2019s interaction with the mesolimbic dopamine reward system","volume":"42","author":"S\u00f6derpalm","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pnpbp.2024.111129_bb0345","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.62878","article-title":"Self-blinding citizen science to explore psychedelic microdosing","volume":"10","author":"Szigeti","year":"2021","journal-title":"Elife"},{"issue":"14","key":"10.1016\/j.pnpbp.2024.111129_bb0350","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1503\/cmaj.141124","article-title":"Psychedelic medicine: a re-emerging therapeutic paradigm","volume":"187","author":"Tupper","year":"2015","journal-title":"CMAJ\u202f: Can.Med. Assoc. J. = J. de l\u2019Assoc. Med. Canadienne"},{"key":"10.1016\/j.pnpbp.2024.111129_bb0355","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000317249","article-title":"Ranking the harm of alcohol, tobacco and illicit drugs for the individual and the population","volume":"16","author":"van Amsterdam","year":"2010","journal-title":"Eur. Addict. Res."},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111129_bb0360","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41583-020-0367-2","article-title":"Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders","volume":"21","author":"Vollenweider","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"issue":"9","key":"10.1016\/j.pnpbp.2024.111129_bb0365","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax4043","article-title":"Advances in the science and treatment of alcohol use disorder","volume":"5","author":"Witkiewitz","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.pnpbp.2024.111129_bb0370","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/TACG.S206745","article-title":"Pharmacogenetics of alcohol addiction: current perspectives","volume":"12","author":"Zastrozhin","year":"2019","journal-title":"Appl. Clin. Genet."},{"key":"10.1016\/j.pnpbp.2024.111129_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2019.116287","article-title":"Rumination and the default mode network: Meta-analysis of brain imaging studies and implications for depression","volume":"206","author":"Zhou","year":"2020","journal-title":"NeuroImage"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624001970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624001970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T10:42:46Z","timestamp":1777545766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584624001970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":77,"alternative-id":["S0278584624001970"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111129","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Classic psychedelics and the treatment for alcoholism","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111129"}}